Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Early Cancer Detection Work Reaps Stanford Cancer Institute Award for Canary FoundationEarly detection of cancer research represents the heart and soul of the work of Canary Foundation in Palo Alto, California, with results ultimately intended to save lives. Stanford Cancer Institute bestowed two awards for exceptional progress.
“The commitment to identifying easy and affordable biomarkers to detect cancer when it is small is the driving force behind the work of Canary Foundation,” Canary Foundation is focused on funding scientific discovery into affordable early detection systems such as blood tests and ultrasound imaging in the fields of ovarian, pancreatic, prostate, breast and lung cancer. “The major way we’re going to make an impact on cancer is early detection and we are thrilled to partner with Canary in this incredible enterprise,” The Stanford Institute of Cancer presented awards for the 2012 outstanding grantmaking foundation, outstanding nonprofit, outstanding individual, and outstanding philanthropist recently in an awards event at Stanford. The Spirit of Hope Award is the highest honor bestowed by the Stanford Cancer Institute to steward cancer research and clinical care missions within the Stanford Medical Center. Also recognized were Lisa Swayze, wife of the late Patrick Swayze, who lost his life to pancreatic cancer, and the national Leukemia and Lymphoma Society. Listwin launched Canary Foundation in 2004. He made a lifelong commitment to apply his resources and expertise to build the first nonprofit organization solely dedicated early cancer detection. Listwin is on the Stanford Advisory Board for the Canary Center at Stanford, and is a member of the Board of Scientific Advisors at the National Cancer Institute. Canary Foundation is the world’s first non-profit organization dedicated solely to the funding, discovery, and development of tests for early cancer detection. Canary Foundation is dedicated to delivering early detection tests for solid cancer tumors within the next 10 years. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|